Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 3Sarcoma 3Dermatologic 2Lymphoid 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 56Triple Negative Breast Neoplasms 28Lung Neoplasms 12Prostatic Neoplasms 10Neoplasm Metastasis 10Carcinoma, Intraductal, Noninfiltrating 10Anatomic Stage I Breast Cancer AJCC v8 9Carcinoma, Non-Small-Cell Lung 8Breast Carcinoma In Situ 8Ovarian Neoplasms 6Melanoma 6Stomach Neoplasms 5Pancreatic Neoplasms 5Meningeal Carcinomatosis 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Multiple Myeloma 4Colonic Neoplasms 4Brain Neoplasms 4Anatomic Stage IV Breast Cancer AJCC v8 4Small Cell Lung Carcinoma 3Inflammatory Breast Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2

Interventions

cabozantinib 1Vorinostat 1Taxes 1Specimen Handling 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Specimen Handling × Breast × Clear all
NCT04514484 2026-05-28

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

National Cancer Institute (NCI)

Phase 1 Active not recruiting
8 enrolled 32 charts
BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Kaposi, HIV Infections, Carcinoma, Medullary, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡